MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
1.345
-0.005 (-0.37%)
Aug 4, 2026, 3:02 PM EDT - Market open
MindWalk Holdings Revenue
In the fiscal year ending April 30, 2026, MindWalk Holdings had annual revenue of 15.56M CAD with 46.41% growth. MindWalk Holdings had revenue of 4.12M in the quarter ending April 30, 2026, with 49.80% growth.
Revenue (ttm)
15.56M CAD
Revenue Growth
+46.41%
P/S Ratio
5.52
Revenue / Employee
202,052 CAD
Employees
77
Market Cap
62.83M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 15.56M | 4.93M | 46.41% |
| Apr 30, 2025 | 10.63M | 347.00K | 3.38% |
| Apr 30, 2024 | 10.28M | -10.39M | -50.26% |
| Apr 30, 2023 | 20.67M | 1.30M | 6.72% |
| Apr 30, 2022 | 19.36M | 1.45M | 8.11% |
| Apr 30, 2021 | 17.91M | 3.85M | 27.41% |
| Apr 30, 2020 | 14.06M | 3.13M | 28.66% |
| Apr 30, 2019 | 10.93M | 5.48M | 100.80% |
| Apr 30, 2018 | 5.44M | 2.81M | 106.85% |
| Apr 30, 2017 | 2.63M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Spero Therapeutics | 61.19M |
| Alps Group | 3.74M |
| ImageneBio | 800.00K |
| MediciNova | 596.64K |
| Cardiff Oncology | 525.00K |
HYFT News
- 7 days ago - MindWalk Holdings Registration statement: Registration filing - Filings
- 11 days ago - MindWalk showcases ReefIQ for AI drug discovery - TheFly
- 11 days ago - MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI - Business Wire
- 12 days ago - MindWalk Holdings Earnings Call Transcript: Q4 2026 - Transcripts
- 12 days ago - MindWalk Holdings Earnings release: Q4 2026 - Filings
- 12 days ago - MindWalk Holdings Annual report: Q4 2026 - Filings
- 12 days ago - MindWalk Holdings Slides: Q4 2026 - Filings
- 12 days ago - MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure - Business Wire